Drugs belonging to class 'Programmed death receptor-1 (PD-1) inhibitor'
See adverse reactions attributed to class 'Programmed death receptor-1 (PD-1) inhibitor'
Drug Name | Compare |
---|---|
Cemiplimab | |
Dostarlimab | |
Nivolumab | |
Pembrolizumab |
Adverse reactions attributed to entire drug class 'Programmed death receptor-1 (PD-1) inhibitor'
Please login to view adverse reactions